GALECTIN THERAPEUTICS INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Galectin Therapeutics Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Galectin Therapeutics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $10M, unchanged year-over-year.
  • Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $40M, a 300% increase from 2022.
  • Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $10M, a 72.8% decline from 2021.
  • Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $36.8M, a 13898% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $40M +$30M +300% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $10M -$26.8M -72.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $36.8M +$36.6M +13898% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $263K -$49.8M -99.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $50.1M +$34.7M +226% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $15.4M +$11.8M +329% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $3.58M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2013 $8.61M -$1.79M -17.2% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-21
2012 $10.4M +$4.21M +67.9% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-21
2011 $6.2M -$2.55M -29.1% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-29
2010 $8.74M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.